Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiping Shao

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Scientific Reports|May 7, 2024
A bionic bird jumping grasping structure design based on stm32 development board controlChunpeng Zhang, Weiping Shao, Yongping Hao
Bioanalysis|September 18, 2020
Assessment of clinically relevant immunogenicity for mAbs; are we over reporting ADA?Mohamed Hassanein, Michael A Partridge, Weiping Shao, et al.
Biochemistry|December 17, 2003
Mapping the binding interface of the cytochrome b5-cytochrome c complex by nuclear magnetic resonanceWeiping Shao, Sang-Choul Im, Erik R P Zuiderweg, et al.
Mathematical Biosciences and Engineering : MBE|December 31, 2020
DeepFireNet: A real-time video fire detection method based on multi-feature fusionBin Zhang, Linkun Sun, Yingjie Song, et al.
Journal of Biomedicine & Biotechnology|December 23, 2003
Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein ProfilingWeiping Shao, Zhimin Zhou, Isabelle Laroche, et al.
Bioanalysis|June 26, 2015
Effects of blood processing and sample storage on the stability of biotherapeutics and anti-drug antibodiesMatthew Andisik, Lisa DeStefano, Colin Stefan, et al.
Journal of Lipids|August 20, 2014
Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-CBeth A Taylor, Gregory Panza, Linda S Pescatello, et al.
The Lancet. Infectious Diseases|June 23, 2018
Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 studySumathi Sivapalasingam, Mohamed Kamal, Rabih Slim, et al.
Nature Biotechnology|March 30, 2002
Multiplexed protein profiling on microarrays by rolling-circle amplificationBarry Schweitzer, Scott Roberts, Brian Grimwade, et al.
Frontiers in Immunology|June 6, 2025
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity PlatformJoanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Scientific Reports|May 7, 2024
A bionic bird jumping grasping structure design based on stm32 development board controlChunpeng Zhang, Weiping Shao, Yongping Hao
Bioanalysis|September 18, 2020
Assessment of clinically relevant immunogenicity for mAbs; are we over reporting ADA?Mohamed Hassanein, Michael A Partridge, Weiping Shao, et al.
Biochemistry|December 17, 2003
Mapping the binding interface of the cytochrome b5-cytochrome c complex by nuclear magnetic resonanceWeiping Shao, Sang-Choul Im, Erik R P Zuiderweg, et al.
Mathematical Biosciences and Engineering : MBE|December 31, 2020
DeepFireNet: A real-time video fire detection method based on multi-feature fusionBin Zhang, Linkun Sun, Yingjie Song, et al.
Journal of Biomedicine & Biotechnology|December 23, 2003
Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein ProfilingWeiping Shao, Zhimin Zhou, Isabelle Laroche, et al.
Bioanalysis|June 26, 2015
Effects of blood processing and sample storage on the stability of biotherapeutics and anti-drug antibodiesMatthew Andisik, Lisa DeStefano, Colin Stefan, et al.
Journal of Lipids|August 20, 2014
Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-CBeth A Taylor, Gregory Panza, Linda S Pescatello, et al.
The Lancet. Infectious Diseases|June 23, 2018
Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 studySumathi Sivapalasingam, Mohamed Kamal, Rabih Slim, et al.
Nature Biotechnology|March 30, 2002
Multiplexed protein profiling on microarrays by rolling-circle amplificationBarry Schweitzer, Scott Roberts, Brian Grimwade, et al.
Frontiers in Immunology|June 6, 2025
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity PlatformJoanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, et al.
Pageof 2